GlassScriptPhysician profile
Andrew Bryant Collins
NPI 1265968770
$1,911.64
in general payments reported to CMS, 2019-2025
23 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $684 · 2022: $403 · 2023: $483 · 2024: $183 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $376.15 | 2021-2022 | |
| Vertos Medical, INC. | $221.39 | 2021-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $210.27 | 2021-2023 | Sprint Pns System |
| Abbvie INC. | $176.35 | 2021-2025 | |
| Medtronic, INC. | $158.68 | 2024-2025 | Kyphon Express II Kyphopak Tray |
| Nalu Medical, INC. | $131.72 | 2021 | |
| Relievant Medsystems, INC. | $118.69 | 2023 | Intracept |
| Novartis Pharmaceuticals Corporation | $86.04 | 2023-2024 | |
| Merz Pharmaceuticals, LLC | $48.62 | 2022 | |
| Spinal Simplicity, LLC | $47.21 | 2022-2023 | Ha Minuteman G3-R |
| Gilead Sciences, INC. | $42.96 | 2021 | |
| Grt US Holding, INC. | $41.63 | 2022 | |
| Eisai INC. | $39.74 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $30.69 | 2023 | Keytruda |
| E.R. Squibb & Sons, L.L.C. | $28.84 | 2023-2024 | Opdivo, Augtyro |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $24.45 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $23.03 | 2021 | |
| Si-Bone, INC. | $19.68 | 2023 | |
| Boston Scientific Corporation | $19.26 | 2025 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $19.12 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.40 | 2022 | |
| Convatec INC. | $15.29 | 2024 | |
| Coherus Oncology, INC. | $13.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.